InChI=1S/C30H41FN4O12/c1- 17(2) 26(29(42) 33- 20(22(36) 15- 31) 13- 24(38) 45- 4) 35- 27(40) 19(11- 12- 23(37) 44- 3) 32- 28(41) 21(14- 25(39) 46- 5) 34- 30(43) 47- 16- 18- 9- 7- 6- 8- 10- 18/h6- 10,17,19- 21,26H,11- 16H2,1- 5H3,(H,32,41) (H,33,42) (H,34,43) (H,35,40) /t19- ,20- ,21- ,26- /m0/s1 |
GBJVAVGBSGRRKN-JYEBCORGSA-N |
N([C@H] (C(N[C@H] (C(N[C@H] (C(N[C@H] (C(CF) =O) CC(=O) OC) =O) C(C) C) =O) CCC(OC) =O) =O) CC(OC) =O) C(OCC=1C=CC=CC1) =O |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
apoptosis inhibitor
Any substance that inhibits the process of apoptosis (programmed cell death) in multi-celled organisms.
EC 3.4.22.56 (caspase-3) inhibitor
An EC 3.4.22.* (cysteine endopeptidase) inhibitor that interferes with the action of caspase-3 (EC 3.4.22.56).
|
|
neuroprotective agent
Any compound that can be used for the treatment of neurodegenerative disorders.
|
|
View more via ChEBI Ontology
benzyloxycarbonyl-Asp(OMe)-Glu(OMe)-Val-Asp(OMe)-fluoromethylketone
|
ChEBI
|
benzyloxycarbonyl-Asp-Glu-Val-Asp-fluoromethylketone
|
ChEBI
|
methyl (4S)- 5- {[(2S)- 1- amino- 3- methyl- 1- oxobutan- 2- yl]amino}- 4- {[(2S)- 2- {[(benzyloxy)carbonyl]amino}- 4- methoxy- 4- oxobutanoyl]amino}- 5- oxopentanoate
|
ChEBI
|
methyl (5S,8S,11S,14S)- 14- (fluoroacetyl)- 11- isopropyl- 5- (2- methoxy- 2- oxoethyl)- 8- (3- methoxy- 3- oxopropyl)- 3,6,9,12- tetraoxo- 1- phenyl- 2- oxa- 4,7,10,13- tetraazahexadecan- 16- oate
|
ChEBI
|
N- [(phenylmethoxy)carbonyl]- L- α- aspartyl- L- α- glutamyl- N- [(1S)- 3- fluoro- 1- (2- methoxy- 2- oxoethyl)- 2- oxopropyl]- L- valinamide, 1,2- dimethyl ester
|
ChEBI
|
specific inhibitor of caspase-3
|
ChEBI
|
Z-Asp(OMe)-Glu(OMe)-Val-Asp(OMe)-fluoromethylketone
|
ChEBI
|
Z-DEVD-fluoromethylketone
|
ChEBI
|
9977166
|
Reaxys Registry Number
|
Reaxys
|
|